Home U.S. cancer doctors drop pricey drugs with little or no effect
 

Keywords :   


U.S. cancer doctors drop pricey drugs with little or no effect

2015-10-08 09:35:52| Chemicals - Topix.net

U.S. oncologists, aware that patients are paying more of the costs of expensive cancer drugs, are increasingly declining to prescribe medicines that have scant or no effect, even as a last resort. At least half a dozen drugs, including colon cancer treatments Cyramza, from Eli Lilly & Co, and Stivarga, sold by Bayer AG, aren't worth prices that can exceed $100,000 a year, top cancer specialists said in interviews with Reuters.

Tags: effect drop cancer drugs

Category:Chemicals

Latest from this category

All news

12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
09.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
08.11Statement from the U.S. Green Building Council on the 2024 Election Results
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
Chemicals »
16.11 & A
16.11
16.11Adley Rutschman__
16.11 L NB42380
16.11
16.11S.H.Figuarts
16.11RUSSELUNO
16.11 5
More »